Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn’s Disease: Report of the TOSCA Study
Geert D’Haens(Amsterdam University Medical Centers), Olaf Stüve(Southwestern Medical Center), Harald Vogelsang(Medical University of Vienna), Séverine Vermeire(KU Leuven), Matthew O. Sikpi(Pfizer (United States)), Robert Clare(Pfizer (United States)), William J. Sandborn(University of San Diego), Richard M. Ransohoff(Cleveland Clinic Lerner College of Medicine), Fabio Cataldi(Pfizer (United States)), Gail M. Comer(Pfizer (United States)), Daniel C. Baumgart(University of Alberta), Matthieu Allez(Inserm), Alaa Ahmad(All India Institute of Medical Sciences), Mina Hassan‐Zahraee(Pfizer (United States)), Sunday Rivers(Pfizer (United States)), Annamarie Kaminski(Pfizer (United States)), Pierre Desreumaux(Active Biotech (Sweden)), Yanhua Zhang(Henan Agricultural University), Vivek Pradhan(Pfizer (United States)), A. Van Gossum(Université Libre de Bruxelles), Kenneth J. Gorelick, Walter Reinisch(Medical University of Vienna), John Cheng(Pfizer (United States))
Cited by 28
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Crohn's disease
|The Lancet|2012|2.1k